Dr. Salem is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3405 Edloe St Ste 300
Houston, TX 77027Phone+1 713-797-1500
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Cornea, External Diseases, and Refractive Surgery, 2015 - 2016
Tulane UniversityResidency, Ophthalmology, 2012 - 2015
MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 2011 - 2012
Georgetown University School of MedicineClass of 2011
Certifications & Licensure
CA State Medical License 2015 - Present
TX State Medical License 2016 - 2026
DC State Medical License 2011 - 2012
VA State Medical License 2011 - 2012- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- 40 citationsSunitinib Inhibits MEK/ERK and SAPK/JNK Pathways and Increases Sodium/Iodide Symporter Expression in Papillary Thyroid CancerMike S. Fenton, Kenneth M. Marion, Andrew K. Salem, Rachel Hogen, Faramarz Naeim
Thyroid. 2010-09-08 - 41 citationsEffect of sunitinib on growth and function of FRTL-5 thyroid cells.Andrew K. Salem, Mike S. Fenton, Kenneth M. Marion, Jerome M. Hershman
Thyroid. 2008-06-25 - 55 citationsThyroid-stimulating hormone increases active transport of perchlorate into thyroid cellsNeil Tran, Liza Valentin-Blasini, Benjamin C. Blount, Caroline Gibbs McCuistion, Mike S. Fenton
American Journal of Physiology. Endocrinology and Metabolism. 2008-04-01
External Links
- Diagnostic Eye Centerhttp://www.diagnosticeyecenter.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
